Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Advate versus Recombinate pharmacokinetic crossover study in severe hemophilia A
2007-004834-18Phase 4Completed
- Sponsor
- Baxter International Inc.
- Start
- Nov 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of recombinant human coagulation factor VIII and Factor VIII in hemophilia A (2 arms), sponsored by Baxter International Inc. Primary endpoint: Area under the plasma concentration-time curve from 0 to 48 hours. Started Nov 2007; status: completed.
02
Drugs
recombinant human coagulation factor VIIIFactor VIII
03
Conditions
hemophilia A
Beyond the preview
Go deeper on 2007-004834-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004834-18.